ABSTRACT
Continuous glucose monitors (CGM) are also available linked with an insulin pump, known as "sensor-augmented pump systems," in which glucose concentrations are conveniently displayed on the pump's screen. Many small studies have utilized CGM to gain a deeper understanding of glucose control in pregnancy and its pathophysiology with diabetes. The evidence base for effectiveness in clinical practice is weak, and additional large well-designed randomized CGM trials are required to inform choices of glucose monitoring techniques. Retrospective CGM (RT-CGM) has been shown to facilitate therapeutic changes as a patient educational tool during complicated by type 1 (T1D) and type 2 (T2D) pregnancy. While multiple randomized controlled clinical trials have shown that sustained use of RT-CGM improves glucose control in nonpregnant T1D populations, there remains a dearth of evidence in T1D pregnancy. The chapter provides the most comprehensive assessment of pump vs. multiple daily injection on glucose control before and during pregnancy.
